Sanofi Q3 Dupixent sales €5.7B, up 34.8%; vaccines sales down 6.6%

Sanofi reported Q3 Dupixent sales of €5.7 billion, up 34.8%, while vaccines sales came in at €3.2 billion, down 6.6%.

Detected & updated continuously · Source: Nebula